Sign in
4

Changes in Ownership

Axsome Therapeutics, Inc. Filed Acc 0001179110-20-004006

Options or other derivatives

  • Director acquired 3,789 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Saad Mark E Director 2020-03-17 Grant or award · Stock Option (Right to Buy) +3,789 3,789 D: show line 1 in the form
Loading xslF345X03/edgar.xml…